These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 25500308
1. Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines. Breard E, Belbis G, Viarouge C, Nomikou K, Haegeman A, De Clercq K, Hudelet P, Hamers C, Moreau F, Lilin T, Durand B, Mertens P, Vitour D, Sailleau C, Zientara S. Vaccine; 2015 Jan 15; 33(4):512-8. PubMed ID: 25500308 [Abstract] [Full Text] [Related]
7. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats. Bréard E, Belbis G, Hamers C, Moulin V, Lilin T, Moreau F, Millemann Y, Montange C, Sailleau C, Durand B, Desprat A, Viarouge C, Hoffmann B, de Smit H, Goutebroze S, Hudelet P, Zientara S. Vaccine; 2011 Mar 16; 29(13):2495-502. PubMed ID: 21256877 [Abstract] [Full Text] [Related]
8. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep. Hamers C, Rehbein S, Hudelet P, Blanchet M, Lapostolle B, Cariou C, Duboeuf M, Goutebroze S. Vaccine; 2009 May 11; 27(21):2789-93. PubMed ID: 19366576 [Abstract] [Full Text] [Related]
9. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy. Savini G, Ronchi GF, Leone A, Ciarelli A, Migliaccio P, Franchi P, Mercante MT, Pini A. Vet Microbiol; 2007 Sep 20; 124(1-2):140-6. PubMed ID: 17499459 [Abstract] [Full Text] [Related]
10. Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17. Speiser KL, Schumaker BA, Cook WE, Cornish TE, Cammack KM, Miller MM. J Am Vet Med Assoc; 2016 May 01; 248(9):1043-9. PubMed ID: 27074613 [Abstract] [Full Text] [Related]
11. Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep. Zulu GB, Venter EH. J S Afr Vet Assoc; 2014 Oct 16; 85(1):1041. PubMed ID: 25686101 [Abstract] [Full Text] [Related]
12. VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA. Feenstra F, Maris-Veldhuis M, Daus FJ, Tacken MG, Moormann RJ, van Gennip RG, van Rijn PA. Vaccine; 2014 Dec 12; 32(52):7108-14. PubMed ID: 25454873 [Abstract] [Full Text] [Related]
13. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection. Stewart M, Dovas CI, Chatzinasiou E, Athmaram TN, Papanastassopoulou M, Papadopoulos O, Roy P. Vaccine; 2012 Mar 09; 30(12):2131-9. PubMed ID: 22285887 [Abstract] [Full Text] [Related]
18. Efficacy of vaccination for bluetongue virus serotype 8 performed shortly before challenge and implications for animal trade. Spedicato M, Lorusso A, Salini R, Gennaro AD, Leone A, Teodori L, Casaccia C, Portanti O, Calistri P, Giovannini A, Savini G. Prev Vet Med; 2017 Jan 01; 136():49-55. PubMed ID: 28010907 [Abstract] [Full Text] [Related]
19. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines. Bartram DJ, Heasman L, Batten CA, Oura CA, Plana-Durán J, Yuen HM, Wylie AD. Vet J; 2011 May 01; 188(2):193-6. PubMed ID: 20466568 [Abstract] [Full Text] [Related]